Detecting fungal infections in blood cancer patients
Part of Blood & lymphatic, Cancer, Infections clinical trials.
This study tests whether a sensitive blood test can find hidden fungal infections in people with blood cancers. It may help your doctor start the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a blood cancer such as leukemia or lymphoma
- You have symptoms or scans that suggest a possible fungal infection
- You are able to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
This trial checks if a blood test can find a fungal lung infection in people with blood cancers or those who had a stem cell transplant. The test looks for fungal DNA in the blood (called mNGS). If it works, it could help doctors diagnose the infection faster and more accurately.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.